Wentworth Kerry
Insider CIK 1369453 · AGEN VP, Clinicial, Reg, & Quality · FLXN Chief Regulatory Officer · NUVB Chief Regulatory Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NUVB Nuvation Bio Inc. | M Exercise deriv | 2026-06-23 | 2026-06-24 | 63,000 | — | $0 | 152,250 | SEC↗ |
| NUVB Nuvation Bio Inc. | M Exercise | 2026-06-23 | 2026-06-24 | 63,000 | $2.93 | $184.6K | 116,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | S Sale | 2026-06-23 | 2026-06-24 | 63,000 | $6.02 | $379.3K | 53,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | M Exercise deriv | 2026-04-17 | 2026-04-21 | 36,750 | — | $0 | 215,250 | SEC↗ |
| NUVB Nuvation Bio Inc. | S Sale | 2026-04-17 | 2026-04-21 | 36,750 | $5.01 | $184.1K | 53,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | M Exercise | 2026-04-17 | 2026-04-21 | 36,750 | $2.93 | $107.7K | 89,750 | SEC↗ |
| NUVB Nuvation Bio Inc. | M Exercise deriv | 2026-04-06 | 2026-04-08 | 100,000 | — | $0 | 300,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | M Exercise deriv | 2026-04-06 | 2026-04-08 | 100,000 | — | $0 | 400,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | M Exercise | 2026-04-06 | 2026-04-08 | 100,000 | $1.87 | $187.0K | 153,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | M Exercise | 2026-04-06 | 2026-04-08 | 100,000 | $1.94 | $194.0K | 253,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | S Sale | 2026-04-06 | 2026-04-08 | 200,000 | $4.52 | $904.0K | 53,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2026-02-27 | 2026-03-03 | 748,130 | — | $0 | 748,130 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2025-06-16 | 2025-06-18 | 26,000 | $1.79 | $46.5K | 26,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2025-06-16 | 2025-06-18 | 24,000 | $1.80 | $43.2K | 50,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2025-02-28 | 2025-03-04 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2024-02-29 | 2024-03-04 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2023-02-28 | 2023-03-02 | 400,000 | — | $0 | 400,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2022-08-29 | 2022-08-31 | 252,000 | — | $0 | 252,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2022-05-23 | 2022-05-25 | 247,500 | — | $0 | 247,500 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2022-05-23 | 2022-05-25 | 330,000 | — | $0 | 330,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 33,333 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 10,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 20,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 35,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 10,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 18,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 15,500 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 20,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 24,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer | 2021-11-19 | 2021-11-19 | 140,843 | $8.50 | $1.20M | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer | 2021-11-19 | 2021-11-19 | 6,000 | $8.50 | $51.0K | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | S Sale | 2021-07-19 | 2021-07-20 | 3,944 | $6.45 | $25.4K | 140,362 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2021-06-21 | 2021-06-28 | 539 | $7.78 | $4.2K | 144,306 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2021-03-01 | 2021-03-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2021-03-01 | 2021-03-03 | 30,000 | — | $0 | 143,767 | SEC↗ |
| FLXN Flexion Therapeutics Inc | S Sale | 2021-01-05 | 2021-01-07 | 6,829 | $11.13 | $76.0K | 113,767 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2020-07-16 | 2020-07-20 | 38,750 | — | $0 | 120,180 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2020-06-22 | 2020-06-24 | 369 | $10.83 | $4.0K | 81,430 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2020-03-02 | 2020-03-03 | 15,500 | — | $0 | 15,500 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2020-03-02 | 2020-03-03 | 31,000 | — | $0 | 81,061 | SEC↗ |
| FLXN Flexion Therapeutics Inc | S Sale | 2020-01-03 | 2020-01-07 | 3,724 | — | $0 | 50,061 | SEC↗ |
| FLXN Flexion Therapeutics Inc | F Tax w/h | 2019-10-07 | 2019-10-08 | 1,002 | $13.98 | $14.0K | 53,394 | SEC↗ |
| FLXN Flexion Therapeutics Inc | M Exercise deriv | 2019-10-06 | 2019-10-08 | 3,400 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | M Exercise | 2019-10-06 | 2019-10-08 | 3,400 | — | $0 | 54,396 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2019-06-21 | 2019-06-24 | 389 | $9.81 | $3.8K | 50,996 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2019-03-01 | 2019-03-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2019-03-01 | 2019-03-05 | 36,000 | — | $0 | 50,607 | SEC↗ |
| FLXN Flexion Therapeutics Inc | S Sale | 2019-01-03 | 2019-01-04 | 622 | $12.36 | $7.7K | 11,207 | SEC↗ |
| FLXN Flexion Therapeutics Inc | F Tax w/h | 2018-10-08 | 2019-03-05 | 1,002 | $18.60 | $18.6K | 14,876 | SEC↗ |
| FLXN Flexion Therapeutics Inc | F Tax w/h | 2018-10-08 | 2018-10-09 | 1,002 | $18.60 | $18.6K | 11,476 | SEC↗ |
| FLXN Flexion Therapeutics Inc | M Exercise deriv | 2018-10-06 | 2019-03-05 | 3,400 | — | $0 | 3,400 | SEC↗ |
| FLXN Flexion Therapeutics Inc | M Exercise | 2018-10-06 | 2019-03-05 | 3,400 | — | $0 | 15,878 | SEC↗ |
| FLXN Flexion Therapeutics Inc | J Other | 2018-06-20 | 2018-06-22 | 171 | $21.22 | $3.6K | 12,478 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2018-02-01 | 2018-02-02 | 33,333 | — | $0 | 33,333 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2018-02-01 | 2018-02-02 | 8,333 | — | $0 | 12,307 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2014-02-26 | 2014-02-28 | 5,000 | $5.00 | $25.0K | 57,410 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2014-02-14 | 2014-02-19 | 130,000 | $3.00 | $390.0K | 100,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2013-09-12 | 2013-09-13 | 40,000 | $2.72 | $108.8K | 40,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2013-06-13 | 2013-06-17 | 47,500 | — | $0 | 47,500 | SEC↗ |
| AGEN AGENUS INC | A Award | 2013-01-28 | 2013-01-29 | 694 | $4.35 | $3.0K | 37,410 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-10-26 | 2012-10-29 | 695 | $4.42 | $3.1K | 36,716 | SEC↗ |
| AGEN AGENUS INC | E Expire deriv | 2012-09-12 | 2012-09-14 | 1,034 | — | $0 | 255,438 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-09-12 | 2012-09-14 | 5,044 | — | $0 | 36,021 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-07-26 | 2012-07-30 | 694 | $4.61 | $3.2K | 30,977 | SEC↗ |
| AGEN AGENUS INC | D To issuer | 2012-06-21 | 2012-06-21 | 14,784 | $5.05 | $74.7K | 30,283 | SEC↗ |
| AGEN AGENUS INC | D To issuer | 2012-06-20 | 2012-06-21 | 14,151 | $4.99 | $70.6K | 45,067 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-06-19 | 2012-06-21 | 14,153 | $5.26 | $74.4K | 59,218 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2012-06-14 | 2012-06-18 | 25,000 | — | $0 | 262,210 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2012-06-14 | 2012-06-18 | 75,000 | $5.34 | $400.5K | 237,210 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-04-26 | 2012-04-30 | 695 | $6.43 | $4.5K | 45,065 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-03-15 | 2012-03-16 | 6,077 | $5.31 | $32.3K | 44,370 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-01-26 | 2012-01-31 | 694 | $2.76 | $1.9K | 38,293 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-01-03 | 2012-01-05 | 22,121 | $2.17 | $48.0K | 37,599 | SEC↗ |